Delivery Order SPE2DR25D2100-SPE2DR26FA1DL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) with a ceiling value of $4,973.46 and a firm fixed price structure. This delivery order, designated as a non-set-aside competitive award, is scheduled for ultimate completion on December 16, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Prevymis 480 mg tablets (quantity: 7 units) under a firm fixed-price contract with a ceiling value of $14,920.38. This is a competitive award with no set-aside designation, and the order is due for completion by January 9, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on January 2, 2026, for the supply of Prevymis 480 mg tablets in quantities of seven units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $5,256.05 and is scheduled for completion by January 26, 2026. The contract represents a child order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9.44K delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Prevymis 480 mg tablets (7-count units), with completion targeted for October 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $5,256.05 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count units) on January 8, 2026, with a completion date of January 30, 2026. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $14.9K delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Prevymis (480 mg tablets, quantity 7) with a completion date of December 3, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing terms and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging) with a ceiling value of $4,719.34. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order and is scheduled for ultimate completion by August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Prevymis 480 mg tablets in a seven-count package configuration. This firm fixed-price delivery order, valued at $9,946.92, represents a non-competitive award and is scheduled for completion by November 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Prevymis 480 mg tablets (seven-count units) with a ceiling value of $9,946.92. This firm fixed price delivery order is expected to be completed by January 12, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's established...
- The Defense Logistics Agency awarded a $4,973.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Prevymis 480 mg tablets (quantity: 7 units). The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of December 31, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA1DLDelivery Order
This contract award represents a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Prevymis (480 mg tablets, 7-count packages) with a ceiling value of $10,512.10. The award was made on January 13, 2026, with an ultimate completion date of February 4, 2026, and utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, designated as SPE2DX and valued at up to $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds a comprehensive master contract with DLA enabling it to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. Prevymis, an antiviral medication used in post-transplant cytomegalovirus prophylaxis, represents one of many specialized pharmaceuticals that AmerisourceBergen delivers through its federal contract portfolio, which historically demonstrates consistent capability to fulfill government medical supply requirements through competitive, open-market procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 1/12/26 |